XCUR Stock Analysis: Buy, Sell, or Hold?
XCUR - Exicure, Inc. Common Stock
$3.24
-0.11 (-3.28%)
▼
5d:
+0.0%
30d:
-20.98%
90d:
-19.6%
WAIT
LOW Confidence
Analysis Updated: May 7, 2026 12:00 AM ET
Earnings: Mar 24, 2026
0d
Get Alerted When XCUR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: XCUR shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: XCUR shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: XCUR is currently trading at $3.24, which is considered oversold relative to its 30-day fair value range of $3.39 to $4.06.
Technical Outlook: Technically, XCUR is in a strong downtrend. The price is currently testing key support at $3.19. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.3% recently.
Market Sentiment: XCUR has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. However, the stock is trading significantly above the average Wall Street target of $2.00. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, XCUR is in a strong downtrend. The price is currently testing key support at $3.19. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.3% recently.
Market Sentiment: XCUR has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. However, the stock is trading significantly above the average Wall Street target of $2.00. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$3.39 -
$4.06
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
42.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.3%)
- BEARISH: Trading 40.3% above Wall St target ($2.00)
Trading Range Analysis
30-Day Trading Range
$3.39 -
$4.06
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$3.19
Resistance Level
$3.60
Current Trend
Strong Downtrend
Technical data as of
May 7, 2026
Fundamental Context
Wall Street Target
$2.00
(-40.3%)
Revenue Growth (YoY)
928.0%
Share & Embed Analysis
Last updated: May 08, 2026 10:26 AM ET
Data refreshes hourly during market hours. Next update: 11:26 AM
Data refreshes hourly during market hours. Next update: 11:26 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XCUR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Sangsangin Investment & …
SELL
433332 shares
2025-12-08
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 53 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$101 | 61 BUY |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$27 | 55 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$131 | 48 HOLD |